CoChat

Screening for Gastric Cancer and Surveillance of Premalignant Lesions: a Systematic Review of Cost‐Effectiveness Studies

Areia, Miguel, Carvalho, Rita, Cadime, Ana Teresa, Rocha Gonçalves, Francisco, Dinis‐Ribeiro, Mário · 2013 · Helicobacter
Cited by 126

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background: Cost‐effectiveness studies are highly dependent on the models, settings, and variables used and should be based on systematic reviews. We systematically reviewed cost‐effectiveness studies that address screening for gastric cancer and/or surveillance of precancerous conditions and lesions. Materials and Methods: A systematic review of cost‐effectiveness studies was performed by conducting a sensitive search in seven databases (PubMed, Scopus, Web of Science, Current Contents Connect, Centre for Reviews and Dissemination, Academic Search Complete, and CINAHL Plus), independently evaluated by two investigators. Articles were evaluated for type of study, perspective, model, intervention, incremental cost‐effectiveness ratio, clinical or cost variables, and quality, according to published guidelines. Results: From 2395 abstracts, 23 articles were included: 19 concerning population screening and 4 on following up premalignant lesions. Studies on Helicobacter pylori screening concluded that serology was cost‐effective, depending on cancer incidence and endoscopy cost (incremental cost‐effectiveness ratio: 6264–25,881), and eradication after endoscopic resection was also cost‐effective (dominant) based on one study. Studies on imaging screening concluded that endoscopy was more cost‐effective than no screening (incremental cost‐effectiveness ratio: 3376–26,836). Articles on follow‐up of premalignant lesions reported conflicting results (incremental cost‐effectiveness ratio: 1868–72,519 for intestinal metaplasia; 18,600–39,800 for dysplasia). Quality assessment revealed a unanimous lack of a detailed systematic review and fulfillment of a median number of 23 items (20–26) of 35 possible ones. Conclusions: The available evidence shows that Helicobacter pylori serology or endoscopic population screening is cost‐effective, while endoscopic surveillance of premalignant gastric lesions presents conflicting results. Better implementation of published guidelines and accomplishment of systematic detailed reviews are needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/hel.12050

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 126

Metadata

Authors
Areia, M., Carvalho, R., Cadime, A. T., Rocha Gonçalves, F., & Dinis‐Ribeiro, M.
Venue
Helicobacter
Publisher
Wiley
Published
2013-04-09
Volume
18
Issue
5
Pages
325-337
ISSN
  • 1083-4389 (ISSN-L)
  • 1523-5378
OpenAlex
W2003093428
Cited by
126
References
5
FWCI
2.42
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Screening for Gastric Cancer and Surveillance of Premalignant Lesions: a Systematic Review of Cost‐Effectiveness Studies. https://app.cochat.ai/papers/10.1111/hel.12050
The paper
Areia, M., Carvalho, R., Cadime, A. T., Rocha Gonçalves, F., & Dinis‐Ribeiro, M. (2013). Screening for Gastric Cancer and Surveillance of Premalignant Lesions: a Systematic Review of Cost‐Effectiveness Studies. Helicobacter. https://doi.org/10.1111/hel.12050

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.